Project Details
Description
The overall goal of the project is to evaluate a strategy for reducing early mortality during antretroviral treatment in settings with high incidence of TB and limited facilities for diagnosing TB in symptomatic, severely immunosuppresssed HIV-infected patients.
Acronym | PROMPT |
---|---|
Status | Finished |
Effective start/end date | 17/09/10 → 1/07/13 |
Funding
- The European & Developing Countries Clinical Trials Partnership : €43,990.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.